Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

433.07
-20.6700-4.56%
Post-market: 433.300.2300+0.05%19:49 EDT
Volume:1.92M
Turnover:837.06M
Market Cap:109.88B
PE:28.27
High:452.00
Open:450.95
Low:431.01
Close:453.74
52wk High:510.77
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.38
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:5.89
PE(LYR):28.27

Loading ...

Vertex EVP and Chief Commercial Officer Duncan McKechnie Disposes of Vertex Pharmaceuticals Common Shares

Reuters
·
Mar 07

BMO Capital Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Mar 06

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Mar 06

Vertex Pharmaceuticals to Join Fireside Chats at Leerink and Barclays Global Healthcare Investor Conferences

Reuters
·
Mar 06

Vertex says JOURNAVX demonstrates ‘effective’ pain management in study

TIPRANKS
·
Mar 05

Vertex Phase 4 Study Shows Journavx Enables Opioid-Free Recovery After Plastic Surgery

Reuters
·
Mar 05

Is Vertex Pharmaceuticals (VRTX) Still Attractively Priced After Its Multi Year Share Price Run?

Simply Wall St.
·
Mar 05

Vertex Pharmaceuticals Files Initial Beneficial Ownership Statement for EVP and Chief Legal Officer Joy Liu

Reuters
·
Mar 04

Vertex CEO and President Reshma Kewalramani Disposes of Common Shares in Vertex Pharmaceuticals Incorporated

Reuters
·
Mar 04

Vertex EVP and CMO Carmen Bozic Disposes of Common Shares

Reuters
·
Mar 04

ACADIA Pharmaceuticals Appoints Jonathan M. Poole to Board of Directors

Reuters
·
Mar 04

Press Release: Vertex Innovations Names Jason Hughes VP of Mission Critical Operations

Dow Jones
·
Mar 04

Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 03

Vertex SVP and Chief Accounting Officer Kristen Ambrose Disposes of Common Shares

Reuters
·
Mar 03

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $600 From $530, Maintains Outperform Rating

MT Newswires Live
·
Mar 02

CRISPR Therapeutics Takeover Chatter With Vertex Puts Investor Tradeoffs In Focus

Simply Wall St.
·
Mar 01

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Vertex Broadens Growth Story With Gene Editing And Non Opioid Pain Therapies

Simply Wall St.
·
Feb 28

Vertex EVP Chief Patient and External Affairs Officer Amit Sachdev Disposes of Vertex Pharmaceuticals Common Shares

Reuters
·
Feb 27

Vertex SVP and Chief Accounting Officer Kristen Ambrose Disposes of Common Shares

Reuters
·
Feb 27